Biogen Idec Income Statement
View: Annual | Quarterly
| Dec 08 | Dec 07 | Dec 06 | |
|---|---|---|---|
| Revenue | 4,097.5 | 3,171.6 | 2,683.0 |
| Cost of Goods Sold | 402.0 | 335.2 | 274.4 |
| Gross Profit | 3,695.5 | 2,836.4 | 2,408.7 |
| Gross Profit Margin | 90.2% | 89.4% | 89.8% |
| SG&A Expense | 925.3 | 776.1 | 685.1 |
| Depreciation & Amortization | 332.7 | 257.5 | 267.0 |
| Operating Income | -- | 951.1 | 493.0 |
| Operating Margin | -- | 30.0% | 18.4% |
| Nonoperating Income | (64.7) | 130.8 | 52.1 |
| Nonoperating Expenses | -- | -- | -- |
| Income Before Taxes | 1,148.9 | 910.6 | 492.2 |
| Income Taxes | 365.8 | 272.4 | 278.4 |
| Net Income After Taxes | 783.2 | 638.2 | 213.7 |
| Continuing Operations | 783.2 | 638.2 | 213.7 |
| Discontinued Operations | -- | -- | -- |
| Total Operations | 783.2 | 638.2 | 213.7 |
| Total Net Income | 783.2 | 638.2 | 213.7 |
| Net Profit Margin | 19.1% | 20.1% | 8.0% |
| Diluted EPS from Total Net Income ($) | 2.65 | 1.99 | 0.63 |
| Dividends per Share | 0.00 | 0.00 | 0.00 |
© 2009 Morningstar, Inc. Financial Data provided by
